Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-10-023659
Filing Date
2010-04-30
Accepted
2010-04-30 17:15:48
Documents
5
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 v183039_10ka.htm 10-K/A 706431
2 v183039_ex31-1.htm EX-31.1 9569
3 v183039_ex31-2.htm EX-31.2 10256
4 v183039_ex32-1.htm EX-32.1 13368
5 v183039_ex32-2.htm EX-32.2 12760
  Complete submission text file 0001144204-10-023659.txt   753940
Mailing Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036
Business Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036 646-214-0700
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33038 | Film No.: 10788779
SIC: 8093 Services-Specialty Outpatient Facilities, NEC